Jh. Luchsinger et Sw. Ricketts, A review of the use of ceftiofur sodium sterile powder for the treatment of equine endometritis, EQUINE PRAC, 22(4), 2000, pp. 16-19
Transient acute endometritis enevitably follows breeding and foaling in mar
es. Mares that develop persistent endometritis exhibit poor fertility, whic
h can be costly to breeders. Persistent endometritis usually is treated by
intrauterine irrigation (infusion) with antibiotic solutions effective agai
nst the implicated pathogens; correction of predisposing anatomic factors,
such as pneumovagina; and cycling the mare with prostaglandin.
Ceftiofur is a late-generation cephalosporin that is active against a wide
range of bacterial pathogens. It is approved in the UK, US, and several oth
er countries for intramuscular administration in the horse for treatment of
bacterial respiratory disease associated with Streptococcus zooepidemicus,
Streptococcus equi, Pasteurella spp, and Staphylococcus spp. It is hypothe
sized that its broad spectrum of activity also might make it suitable for t
reating equine endometritis.
Ceftiofur sodium has demonstrated activity against aerobic bacterial isolat
es from mares with endometritis. It was equivalent to or significantly more
active in vitro than gentamicin, amikacin, penicillin G, and ticarcillin a
gainst Staphylococcus, Streptococcus, and Enterobacteriaceae spp. Serum and
endometrial tissue concentrations of ceftiofur peaked at 1 hour after intr
amuscular administration of 2 mg/kg body weight, and endometrial levels exc
eeded the minimal inhibitory concentrations (MIC) for S zooepidemicus and E
scherichia coli.
In field trials, ceftiofur administered as an intrauterine treatment proved
significantly better than treatment with saline solution, in increasing th
e conception rate, decreasing services to conception, and improving the fer
tility rate. It was also less irritating to the endometrial mucosae than wa
s sterile saline. Finally, resolution of acute endometritis (based on endom
etrial culture and cytologic studies) in ceftiofur-treated mares occurred n
umerically more frequently than in mares treated with a mixture of benzylpe
nicillin, neomycin, polymixin, and furaltadone. A review of the existing mi
crobial susceptibility, pharmacokinetic, and efficacy data suggests that ce
ftiofur will be both safe and effective for the treatment of equine endomet
ritis.